期刊文献+

Hepatocellular carcinoma mouse models:Hepatitis B virusassociatedhepatocarcinogenesis and haploinsufficienttumor suppressor genes 被引量:5

Hepatocellular carcinoma mouse models: Hepatitis B virusassociated hepatocarcinogenesis and haploinsufficient tumor suppressor genes
下载PDF
导出
摘要 The multifactorial and multistage pathogenesis of hepatocellular carcinoma(HCC)has fascinated a wide spectrum of scientists for decades.While a number of major risk factors have been identified,their mechanistic roles in hepatocarcinogenesis still need to be elucidated.Many tumor suppressor genes(TSGs)have been identified as being involved in HCC.These TSGs can be classified into two groups depending on the situation with respect to allelic mutation/loss in the tumors:the recessive TSGs with two required mutated alleles and the haploinsufficient TSGs with one required mutated allele.Hepatitis B virus(HBV)is one of the most important risk factors associated with HCC.Although mice cannot be infected with HBV due to the narrow host range of HBV and the lack of a proper receptor,one advantage of mouse models for HBV/HCC research is the numerous and powerfulgenetic tools that help investigate the phenotypic effects of viral proteins and allow the dissection of the dose-dependent action of TSGs.Here,we mainly focus on the application of mouse models in relation to HBV-associated HCC and on TSGs that act either in a recessive or in a haploinsufficient manner.Discoveries obtained using mouse models will have a great impact on HCC translational medicine. The multifactorial and multistage pathogenesis of hepatocellular carcinoma(HCC)has fascinated a wide spectrum of scientists for decades.While a number of major risk factors have been identified,their mechanistic roles in hepatocarcinogenesis still need to be elucidated.Many tumor suppressor genes(TSGs)have been identified as being involved in HCC.These TSGs can be classified into two groups depending on the situation with respect to allelic mutation/loss in the tumors:the recessive TSGs with two required mutated alleles and the haploinsufficient TSGs with one required mutated allele.Hepatitis B virus(HBV)is one of the most important risk factors associated with HCC.Although mice cannot be infected with HBV due to the narrow host range of HBV and the lack of a proper receptor,one advantage of mouse models for HBV/HCC research is the numerous and powerfulgenetic tools that help investigate the phenotypic effects of viral proteins and allow the dissection of the dose-dependent action of TSGs.Here,we mainly focus on the application of mouse models in relation to HBV-associated HCC and on TSGs that act either in a recessive or in a haploinsufficient manner.Discoveries obtained using mouse models will have a great impact on HCC translational medicine.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第1期300-325,共26页 世界胃肠病学杂志(英文版)
基金 Supported by Research grants from the Ministry of Science and Technology(MOST)in Taiwan,No.NSC99-2628-B-010-001-MY3,MOST 103-2321-B-010-003,MOST 103-2633-H-010-001,MOST 103-2633-B-400-002 and MOST104-3011-B-010-001 a grant from the Ministry of Education,Aim for the Top University Plan
关键词 HEPATOCELLULAR carcinoma Mouse models Hepatitis B virus HAPLOINSUFFICIENCY Tumor suppressorgenes Hepatocellular carcinoma Mouse models Hepatitis B virus Haploinsufficiency Tumor suppressor genes
  • 相关文献

参考文献246

  • 1El-Serag HB. Epidemiology of viral hepatitis and hepatocellularcarcinoma. Gastroenterology 2012; 142: 1264-1273.e1 [PMID:22537432 DOI: 10.1053/j.gastro.2011.12.061].
  • 2Bakiri L, Wagner EF. Mouse models for liver cancer. MolOncol 2013; 7: 206-223 [PMID: 23428636 DOI: 10.1016/j.molonc.2013.01.005].
  • 3Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinomaepidemiology. Best Pract Res Clin Gastroenterol 2014; 28: 753-770[PMID: 25260306 DOI: 10.1016/j.bpg.2014.08.007].
  • 4Li Y, Tang ZY, Hou JX. Hepatocellular carcinoma: insight fromanimal models. Nat Rev Gastroenterol Hepatol 2012; 9: 32-43[PMID: 22025031 DOI: 10.1038/nrgastro.2011.196].
  • 5Thorgeirsson SS, Grisham JW. Molecular pathogenesis of humanhepatocellular carcinoma. Nat Genet 2002; 31: 339-346 [PMID:12149612 DOI: 10.1038/ng0802-339].
  • 6Cougot D, Neuveut C, Buendia MA. HBV induced carcinogenesis.J Clin Virol 2005; 34 Suppl 1: S75-S78 [PMID: 16461228 DOI:10.1016/S1386-6532(05)80014-9].
  • 7Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C. HepatitisB virus-related hepatocellular carcinoma: paradigms for viral-relatedhuman carcinogenesis. Oncogene 2006; 25: 3823-3833 [PMID:16799624 DOI: 10.1038/sj.onc.1209559].
  • 8Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY,Sun CA, Lu SN, Chen DS, Chen CJ. Metabolic factors and riskof hepatocellular carcinoma by chronic hepatitis B/C infection: afollow-up study in Taiwan. Gastroenterology 2008; 135: 111-121[PMID: 18505690 DOI: 10.1053/j.gastro.2008.03.073].
  • 9Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, IloejeUH. Risk of hepatocellular carcinoma across a biological gradient ofserum hepatitis B virus DNA level. JAMA 2006; 295: 65-73 [PMID:16391218 DOI: 10.1001/jama.295.1.65].
  • 10Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ. Viral hepatocarcinogenesis:from infection to cancer. Liver Int 2008; 28: 175-188[DOI: 10.1111/j.1478-3231.2007.01652.x].

同被引文献16

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部